We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

107 hedge funds and large institutions have $263M invested in BioSpecifics Technologies Corp. in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 40 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 7

15% more funds holding

Funds holding: 93 → 107 (+14)

8% more capital invested

Capital invested by funds: $244M → $263M (+$19M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

23% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 40

Holders
107
Holders Change
+14
Holders Change %
+15.05%
% of All Funds
2.38%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
21
Increased
31
Reduced
40
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$5.77M
2
RHJA
Rice Hall James & Associates
California
+$4.16M
3
American Century Companies
American Century Companies
Missouri
+$1.85M
4
BlackRock
BlackRock
New York
+$1.6M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$1.43M

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$4.05M
2
EAM
Eagle Asset Management
Florida
-$1.7M
3
BCM
Bridgeway Capital Management
Texas
-$1.61M
4
TAM
THB Asset Management
Connecticut
-$1.19M
5
PVI
Pura Vida Investments
New York
-$1.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
26
ClariVest Asset Management
California
$2.5M +$683K +11,433 +38%
ACA
27
Apis Capital Advisors
New York
$2.42M +$2.39M +40,000 New
American Century Companies
28
American Century Companies
Missouri
$2.42M +$1.85M +30,894 +341%
Man Group
29
Man Group
United Kingdom
$2.06M -$5.97K -100 -0.3%
OAM
30
Oxford Asset Management
United Kingdom
$2.04M -$66.9K -1,120 -3%
TCIM
31
TIAA CREF Investment Management
New York
$1.95M -$192K -3,220 -9%
MCM
32
Matarin Capital Management
New York
$1.64M +$260K +4,359 +19%
Russell Investments Group
33
Russell Investments Group
United Kingdom
$1.47M +$299K +5,004 +26%
Assenagon Asset Management
34
Assenagon Asset Management
Luxembourg
$1.45M +$1.43M +23,879 New
Invesco
35
Invesco
Georgia
$1.45M -$112K -1,876 -7%
EGI
36
EAM Global Investors
California
$1.38M +$128K +2,147 +10%
EP
37
Eversept Partners
New York
$1.33M +$5.97K +100 +0.5%
IP
38
Isthmus Partners
Wisconsin
$1.28M +$92.7K +1,552 +8%
Millennium Management
39
Millennium Management
New York
$1.27M +$1.25M +20,989 New
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$1.1M – – –
EI
41
EAM Investors
California
$1.07M +$79.3K +1,328 +8%
BCM
42
Bridgeway Capital Management
Texas
$1.01M -$1.61M -26,900 -62%
NC
43
Northpointe Capital
Michigan
$994K +$980K +16,396 New
PPA
44
Parametric Portfolio Associates
Washington
$925K +$228K +3,813 +33%
Two Sigma Advisers
45
Two Sigma Advisers
New York
$745K -$102K -1,700 -12%
TA
46
Teachers Advisors
New York
$678K +$70.6K +1,182 +12%
Morgan Stanley
47
Morgan Stanley
New York
$605K -$1.13M -18,914 -65%
DCM
48
Dupont Capital Management
Delaware
$604K +$596K +9,968 New
Swiss National Bank
49
Swiss National Bank
Switzerland
$588K +$580K +9,700 New
SO
50
STRS Ohio
Ohio
$569K -$179K -3,000 -24%
1
2
3 4 5

BSTC Hedge Fund Activity: Q4 2018 in Review

107 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2018, worth a combined $263M — up 7.8% from $244M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new BSTC positions and 7 closed out — a net gain of 14 holders — while 31 added to existing stakes and 40 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $5.77M. The largest seller was Stonepine Capital Management, cutting an estimated $4.05M.

  • 107 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q4 2018, up from 93 in Q3 2018.
  • Funds reported $263M of BioSpecifics Technologies Corp. stock for Q4 2018, up 7.8% quarter-over-quarter.
  • 21 funds opened new BioSpecifics Technologies Corp. positions in Q4 2018 and 7 closed out, a net change of +14 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q4 2018 was Goldman Sachs, an estimated $5.77M added.
  • The largest BioSpecifics Technologies Corp. seller in Q4 2018 was Stonepine Capital Management, an estimated $4.05M sold.

Based on aggregated 13F filings for Q4 2018.